Webinar Date & Time
12 November 2025 from 04:00 PM to 05:30 PM (CET)
Webinar Overview
Finding and engaging the right patients for clinical trials remains one of the industry’s greatest challenges—particularly when those patients are underdiagnosed, underrepresented, or unaware that their symptoms may qualify them for participation. In many therapeutic areas, from women’s health to rare diseases, the recruitment journey begins not at the point of consent, but at the point of awareness.
In this webinar, Dr. Tobias Kruse, Managing Director Europe at SubjectWell, will discuss how social media can improve clinical trial recruitment from awareness to enrollment. He will present data from SubjectWell’s two recent peer-reviewed publications in JMIR and JMIR Mental Health, discussing how tools such as the Patient Burden Index (PBI) and Site Burden Index (SBI), along with real-world evidence (RWE) studies and targeted digital recruitment campaigns, can help you better understand both your study protocol and patient population to enhance recruitment outcomes. Dr. Kruse will also examine the benefits and challenges of using social media for patient recruitment and provide an overview of the current regulatory environment in Europe.
Join us to explore how the intersection of social media, science, and patient recruitment is reshaping patient enrollment timelines—and helping clinical trials reach the patients who need them most.es.
Presenter
Dr. Tobias Kruse
Managing Director of Europe
SubjectWell, Inc.
Dr. Tobias Kruse is the Managing Director of Europe at SubjectWell. He is the founder and former CEO of Trials24, a company that supports biotech and pharmaceutical companies, as well as CROs, in accelerating patient recruitment. Trials24 was acquired by SubjectWell in September 2024. Before founding Trials24, Tobias co-founded ImevaX, a biotech company focused on vaccine development, where he developed and executed the out-of-site databases patient recruitment strategy. Tobias earned his PhD in Molecular Biotechnology from the Technical University of Munich, where he developed a vaccine against Helicobacter pylori. He holds numerous patents and has published papers in journals such as Nature, EMBO, and JMIR.
Attendance Fee
€ 90,- for non-EUCROF members
€ 60,- for EUCROF members
Deadline for registration
11 November 2025 at 6 p.m.
How to register?
1) Go on the REGISTRATION PAGE and click on the orange button “GET TICKETS”
2) Check your order and click on the green “CHECKOUT” button
3) Fill in all the necessary information and validate your order
Confirmation
You will receive 2 confirmation emails:
A) One from Eventbrite with your invoice
B) One from “Eucrof” with all the necessary information to connect the D-Day!
Questions?
Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at webinar@eucrof.eu
By registering to the webinar, you give your authorisation to the webinar organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at info@eucrof.eu.
